Deltagen Inc
Deltagen Inc. provides drug discovery tools and services to the biopharmaceutical industry. The company offers a suite of programs designed to enhance the efficiency of drug discovery, including access to biological models, as well as small-molecule and secreted protein drug targets. It also provides target validation data in the areas of immunology and metabolic diseases. The company was incorpo… Read more
Deltagen Inc (DGEN) - Total Liabilities
Latest total liabilities as of December 2014: $124.00K USD
Based on the latest financial reports, Deltagen Inc (DGEN) has total liabilities worth $124.00K USD as of December 2014.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Deltagen Inc - Total Liabilities Trend (1999–2015)
This chart illustrates how Deltagen Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Deltagen Inc Competitors by Total Liabilities
The table below lists competitors of Deltagen Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Santa Fe Petroleum Inc
PINK:SFPI
|
USA | $1.41 Million |
|
China Yanyuan Yuhui National Education Group Inc
PINK:YYYH
|
USA | $1.87 Million |
|
Standard Energy Corp
PINK:STDE
|
USA | $282.40K |
|
Sfsb Inc
PINK:SFBI
|
USA | $25.00K |
|
SNM Gobal Holdings
PINK:SNMN
|
USA | $2.14 Million |
|
Matmown Inc
PINK:MTMW
|
USA | $1.44 Million |
|
Gooi Global Inc
PINK:GOOI
|
USA | $10.79 Million |
|
Shengkai Innovations Inc
PINK:VALV
|
USA | $3.03 Million |
Liability Composition Analysis (1999–2015)
This chart breaks down Deltagen Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.30 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.07 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.07 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Deltagen Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Deltagen Inc (1999–2015)
The table below shows the annual total liabilities of Deltagen Inc from 1999 to 2015.
| Year | Total Liabilities | Change |
|---|---|---|
| 2015-12-31 | $129.00K | +4.03% |
| 2014-12-31 | $124.00K | -72.07% |
| 2013-12-31 | $444.00K | +10.72% |
| 2012-12-31 | $401.00K | +24.53% |
| 2010-12-31 | $322.00K | +26.77% |
| 2009-12-31 | $254.00K | -55.12% |
| 2008-12-31 | $566.00K | -34.57% |
| 2007-12-31 | $865.00K | +2.98% |
| 2006-12-31 | $840.00K | -86.08% |
| 2005-12-31 | $6.04 Million | -88.38% |
| 2002-12-31 | $51.95 Million | +104.71% |
| 2001-12-31 | $25.38 Million | +32.22% |
| 2000-12-31 | $19.20 Million | -13.31% |
| 1999-12-31 | $22.14 Million | -- |